Skip to Content
Merck
CN
  • Topical and systemic therapies for oral and perioral herpes simplex virus infections.

Topical and systemic therapies for oral and perioral herpes simplex virus infections.

Journal of the California Dental Association (2013-05-28)
Eric T Stoopler, Ramesh Balasubramaniam
ABSTRACT

Oral and perioral herpes simplex virus (HSV) infections in healthy individuals often present with signs and symptoms that are clearly recognized by oral health care providers (OHCPs). Management of these infections is dependent upon a variety of factors and several agents may be used for treatment to accelerate healing and decrease symptoms associated with lesions. This article will review the pertinent aspects of topical and systemic therapies of HSV infections for the OHCP.

MATERIALS
Product Number
Brand
Product Description

Aciclovir, European Pharmacopoeia (EP) Reference Standard
SAFC
L-Valine
Sigma-Aldrich
2-Aminopurine, ≥99%
Supelco
Acyclovir, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Acycloguanosine, ≥99% (HPLC), powder
Sigma-Aldrich
L-Valine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Supelco
L-Valine, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
L-Valine, reagent grade, ≥98% (HPLC)
Sigma-Aldrich
L-Valine, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
Valacyclovir hydrochloride hydrate, ≥98% (HPLC), solid
Supelco
L-Valine, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Famciclovir, ≥98% (HPLC)